Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315433473> ?p ?o ?g. }
- W4315433473 endingPage "904" @default.
- W4315433473 startingPage "897" @default.
- W4315433473 abstract "Waldenström macroglobulinaemia (WM) is characterized by the presence of a MYD88L265P mutation. This mutation promotes growth and survival of malignant cells through Bruton tyrosine kinase (BTK) activation. Ibrutinib was the first BTK inhibitor approved for WM. Intolerance to ibrutinib frequently leads to dose reductions, though the impact of reducing ibrutinib dosing has not been systematically studied. We performed a retrospective study to determine the frequency and impact of reducing ibrutinib dosing in WM patients. With a median treatment time of 64 months, 96 (27%) of 353 WM patients required a dose reduction due to adverse events such as musculoskeletal symptoms, cardiac events, dermatologic symptoms, cytopenias, and gastrointestinal symptoms. The median time to initial dose reduction was 9.3 months (range, 0.5-74). Dose reductions were more common in those 65 years of age or older versus under 65 [hazard ratio (HR) 2.46, 95% confidence interval (CI) 1.55-3.90; p < 0.001], and in females versus males (HR 2.20, 95% CI 1.41-3.28, p < 0.001). Most patients (65%) had improvement or resolution of adverse effects after initial dose reduction. With a median follow-up of three years from dose reduction, hematologic response sustained or deepened in 79% of patients. These data suggest that dose reduction of ibrutinib is a reasonable treatment approach for patients with intolerable side effects." @default.
- W4315433473 created "2023-01-11" @default.
- W4315433473 creator A5024726033 @default.
- W4315433473 creator A5054952526 @default.
- W4315433473 creator A5055168389 @default.
- W4315433473 creator A5057808223 @default.
- W4315433473 creator A5064317133 @default.
- W4315433473 creator A5067459987 @default.
- W4315433473 creator A5068329783 @default.
- W4315433473 creator A5070629260 @default.
- W4315433473 creator A5081299017 @default.
- W4315433473 date "2023-01-10" @default.
- W4315433473 modified "2023-09-30" @default.
- W4315433473 title "Dose reductions in patients with Waldenström macroglobulinaemia treated with ibrutinib" @default.
- W4315433473 cites W1986924929 @default.
- W4315433473 cites W2006422013 @default.
- W4315433473 cites W2037983836 @default.
- W4315433473 cites W2042887247 @default.
- W4315433473 cites W2050974188 @default.
- W4315433473 cites W2108206643 @default.
- W4315433473 cites W2117582823 @default.
- W4315433473 cites W2133192145 @default.
- W4315433473 cites W2171771895 @default.
- W4315433473 cites W2282814231 @default.
- W4315433473 cites W2590804070 @default.
- W4315433473 cites W2597500221 @default.
- W4315433473 cites W2805689516 @default.
- W4315433473 cites W2884164278 @default.
- W4315433473 cites W2907375267 @default.
- W4315433473 cites W2971082993 @default.
- W4315433473 cites W3033875770 @default.
- W4315433473 cites W3046825703 @default.
- W4315433473 cites W3085746633 @default.
- W4315433473 cites W3185756680 @default.
- W4315433473 cites W3199200396 @default.
- W4315433473 cites W3203864709 @default.
- W4315433473 cites W3211781751 @default.
- W4315433473 doi "https://doi.org/10.1111/bjh.18643" @default.
- W4315433473 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36626914" @default.
- W4315433473 hasPublicationYear "2023" @default.
- W4315433473 type Work @default.
- W4315433473 citedByCount "6" @default.
- W4315433473 countsByYear W43154334732023 @default.
- W4315433473 crossrefType "journal-article" @default.
- W4315433473 hasAuthorship W4315433473A5024726033 @default.
- W4315433473 hasAuthorship W4315433473A5054952526 @default.
- W4315433473 hasAuthorship W4315433473A5055168389 @default.
- W4315433473 hasAuthorship W4315433473A5057808223 @default.
- W4315433473 hasAuthorship W4315433473A5064317133 @default.
- W4315433473 hasAuthorship W4315433473A5067459987 @default.
- W4315433473 hasAuthorship W4315433473A5068329783 @default.
- W4315433473 hasAuthorship W4315433473A5070629260 @default.
- W4315433473 hasAuthorship W4315433473A5081299017 @default.
- W4315433473 hasBestOaLocation W43154334731 @default.
- W4315433473 hasConcept C126322002 @default.
- W4315433473 hasConcept C143998085 @default.
- W4315433473 hasConcept C170493617 @default.
- W4315433473 hasConcept C197934379 @default.
- W4315433473 hasConcept C207103383 @default.
- W4315433473 hasConcept C2777288759 @default.
- W4315433473 hasConcept C2777938653 @default.
- W4315433473 hasConcept C2778461978 @default.
- W4315433473 hasConcept C2779338263 @default.
- W4315433473 hasConcept C2779878957 @default.
- W4315433473 hasConcept C2781038049 @default.
- W4315433473 hasConcept C42362537 @default.
- W4315433473 hasConcept C44249647 @default.
- W4315433473 hasConcept C71924100 @default.
- W4315433473 hasConcept C90059517 @default.
- W4315433473 hasConcept C90924648 @default.
- W4315433473 hasConceptScore W4315433473C126322002 @default.
- W4315433473 hasConceptScore W4315433473C143998085 @default.
- W4315433473 hasConceptScore W4315433473C170493617 @default.
- W4315433473 hasConceptScore W4315433473C197934379 @default.
- W4315433473 hasConceptScore W4315433473C207103383 @default.
- W4315433473 hasConceptScore W4315433473C2777288759 @default.
- W4315433473 hasConceptScore W4315433473C2777938653 @default.
- W4315433473 hasConceptScore W4315433473C2778461978 @default.
- W4315433473 hasConceptScore W4315433473C2779338263 @default.
- W4315433473 hasConceptScore W4315433473C2779878957 @default.
- W4315433473 hasConceptScore W4315433473C2781038049 @default.
- W4315433473 hasConceptScore W4315433473C42362537 @default.
- W4315433473 hasConceptScore W4315433473C44249647 @default.
- W4315433473 hasConceptScore W4315433473C71924100 @default.
- W4315433473 hasConceptScore W4315433473C90059517 @default.
- W4315433473 hasConceptScore W4315433473C90924648 @default.
- W4315433473 hasIssue "5" @default.
- W4315433473 hasLocation W43154334731 @default.
- W4315433473 hasLocation W43154334732 @default.
- W4315433473 hasOpenAccess W4315433473 @default.
- W4315433473 hasPrimaryLocation W43154334731 @default.
- W4315433473 hasRelatedWork W2411767449 @default.
- W4315433473 hasRelatedWork W2430850754 @default.
- W4315433473 hasRelatedWork W2527858834 @default.
- W4315433473 hasRelatedWork W2614001962 @default.
- W4315433473 hasRelatedWork W2806698461 @default.
- W4315433473 hasRelatedWork W2884827948 @default.
- W4315433473 hasRelatedWork W2912256758 @default.